Clinical trials test for the first time for more effective interventional drug treatment s/he can be in stroke

The vertebral underlying artery is an important blood supply artery in the brain, and if it is closed, it triggers a stroke that can lead to severe disability, even coma and deathIn recent years, intravascular interventional therapy has provided a new method for acute stage treatment of stroke, but the efficacy of post-circulating stroke caused by vertebral underlying arterial infarcor cordering has not been confirmed in clinical trials" this type of condition, the patient is often on the brink of death, if the cerebrovascular intervention treatment, the risk of surgery is very highAt present, patients are more likely to be treated with medication, but the rate of cerebrovascular re-penetration of the vertebral underlying artery reclusorist rt-PA venous thrombosis drug is only 30%Starting in April 2015, 28 hospitals in the United Nations, Liu Xinfeng, launched the BEST study, which randomly divided patients with acute vertebral underlying artery infarct for 8 hours into intravascular therapy group (hereinafter referred to as the intervention group) and the drug treatment group, comparing the effectiveness and safety of the two treatments" interventiongroup of patients, using a combination of interventional therapy and drug therapyWe use stent hydrant, stent implantation, balloon expansion, arterial thrombosis and other treatment as appropriate, depending on the patient's conditionAfter 90 days of observation, the mortality rate of patients in the interventional group decreased by 15 percent and the clinical prognosis improvement rate was about 20 percent, Liu said" means that cerebrovascular interventional therapy is better than simple drug therapy and is effective in treating cerebral infarction caused by the vertebral underlying arteriesLiu Xinfeng said.